-
PCI Biotech and MDimune form research collaboration
OSLO, NORWAY: PCI Biotech, a Norwegian cancer focused biopharmaceutical company and MDimune Inc., a private South Korean biotech company developing innovative drug delivery technologies for modifying cellular and disease processes in many areas of human disease, announced a preclinical research collaboration that would offer several opportunities for future development. Commenting on the announcement, Per…
-
Nordic Nanovector enters research collaboration with University of Pennsylvania
OSLO, NORWAY: Nordic Nanovector ASA has entered into a research collaboration with the University of Pennsylvania to generate a CD37-targeting CAR-T cell approach as a potential treatment for patients with B-cell malignancies. The collaboration aims to combine Nordic Nanovector’s expertise around CD37, a protein present on the surface of B-cell tumour cells, with the…
-
PME’s U.S. subsidiary signs Research Collaboration agreement with NYU Langone Health
MELBOURNE: Visage Imaging Inc., U.S. subsidiary of Pro Medicus Limited [PME], has signed a multi-year Research Collaboration agreement with NYU Langone Health, one of the most highly regarded health systems in North America. Under the terms of the agreement, the two parties will work together to design and develop next-generation products for enterprise imaging…
-
PCI Biotech forms research collaboration with DCprime
OSLO: PCI Biotech has announced an extensive research collaboration. Within the collaboration, DCprime and PCI Biotech will combine their know-how and technology platforms to pursue the development of novel cancer vaccination concepts based on tumour-independent antigens (TIAs). PCI Biotech is a biopharmaceutical late stage clinical development company focusing on development and commercialisation of novel …
